Stoma & Ostomy Care Market Size, Share, Growth, And Industry Analysis by Type (Ostomy Care Bags, Ostomy Care Accessories) by Application (Home Care, Hospitals, Ambulatory Surgical Centers) and Regional Forecast From 2026-2035

• 

  Download Free Sample to learn more about this report

STOMA & OSTOMY CARE MARKET OVERVIEW

The stoma & ostomy care market globally is expected to be valued at USD 0.92 Billion in 2026. It is forecasted to increase to USD 1.36 Billion by 2035. This reflects a compound annual growth rate CAGR of 4.1% between 2026 to 2035.

The stoma & ostomy care market supports people who live with a surgically created opening that diverts waste from the bowel or urinary tract. Products include ostomy care bags, skin barriers, adhesive removers, belts, pastes, powders and odor control accessories that patients replace on a regular schedule. This recurring replacement cycle gives the stoma & ostomy care market stable demand across hospitals, specialty clinics and home care settings. Ostomy care bags hold 64% share, while North America leads regionally with 36% share. Established manufacturers such as Hollister Incorporated, operating since 1921, continue to refine barrier technology, comfort and discretion to improve patient confidence and everyday independence.

The United States stoma & ostomy care market benefits from a mature healthcare system, organized patient advocacy and broad insurance coverage for ostomy supplies. Colorectal cancer, inflammatory bowel disease and bladder cancer surgeries create a steady inflow of new patients who need pouching systems and skin protection products. Home delivery suppliers, durable medical equipment providers and wound ostomy continence nurses guide product selection and follow up care. Hollister Incorporated, headquartered in Libertyville, Illinois, and Coloplast hold strong positions through nurse education, sample programs and patient support services. Demand for convex systems, moldable barriers and ceramide infused skin care keeps rising among American ostomates, who increasingly expect discreet, comfortable and reliable products.

KEY FINDINGS

LATEST TRENDS

Rise of Digital Health Solutions Helps Market to Grow

Digital leakage detection is among the most visible trends in the stoma & ostomy care market. Coloplast introduced Heylo in 2024, a sensor based notification system that alerts users when output reaches the barrier edge, which reduces anxiety and unexpected leaks. Soft convex design is another leading trend. Convatec positioned Esteem Body as a soft convex product with leak defense and water repellent fabric, and the product continues to gain share. Natura Body, a 2-piece soft convex system, is also in development.

Subscription and home delivery models are growing as patients prefer to receive supplies at their doors with nurse guided support. Telehealth consultations with stoma nurses extend clinical access to rural patients. In financial year 2025/26, Coloplast reported 6% organic growth in ostomy care, which reflects sustained demand for premium pouching systems. Sustainability is also gaining attention, with companies reviewing recyclable packaging and lower plastic content in pouches.

Download Free Sample to learn more about this report

STOMA & OSTOMY CARE MARKET SEGMENTATION

By Type

Based on Type the global market can be categorized into Ostomy Care Bags and Ostomy Care Accessories.

• Ostomy Care Bags: Ostomy care bags hold 64% share of the stoma & ostomy care market because every patient with a stoma needs a pouch. The segment includes drainable, closed and urostomy pouches in 1-piece and 2-piece formats, with options for flat, convex and moldable barriers. Users value odor barrier films, gas filters, soft outer fabric and secure closures that protect confidence during work and travel. Recent launches focus on leak defense, water repellent materials and neutral or black colors for discretion. Ileostomy and urostomy patients change or empty pouches frequently, which supports repeat purchase. 

• Ostomy Care Accessories; Ostomy care accessories represent 36% share and are growing in importance as patients look for better skin protection and longer wear time. The segment covers barrier rings, strips, pastes, powders, adhesive removers, belts, deodorants, skin protectants and irrigation sleeves. Brava from Coloplast and Adapt from Hollister Incorporated show how accessory ranges can address leakage, uneven skin surfaces and hernia support. Accessories typically carry attractive repeat purchase patterns because patients add them to their pouching routine after nurse advice or a skin complication. As awareness of peristomal skin health increases, accessories are shifting from optional add-ons to essential parts of complete ostomy care routines.

By Application

• Home Care: Home care leads with 57% share because most ostomy management happens outside the hospital after patients are discharged. Patients and caregivers change pouches, clean skin and reorder supplies on a regular schedule, which creates dependable consumable demand. Home delivery suppliers, community stoma nurses and online ordering platforms make access simple and discreet. Manufacturers support this setting with sample programs, education videos, mobile applications and telephone helplines. Earlier discharge after colorectal surgery also moves training and follow up into the home. Convenience, privacy and ongoing nurse guidance make home care the strongest application for the stoma & ostomy care market.

• Hospitals & Ambulatory Surgical Centers: Hospitals & ambulatory surgical centers account for 43% share and act as the entry point for new ostomy patients. Surgeons, wound ostomy continence nurses and ward staff select the initial pouching system, mark stoma sites before surgery and teach basic care. Hospital contracts, group purchasing and nurse preferences influence which brands patients meet early, and familiarity often leads to long term loyalty. Ambulatory surgical centers add growth as more minimally invasive procedures move to outpatient settings. Hospitals also purchase specialized products for complications such as retracted stomas, high output ileostomies and fragile skin. Education and product trial programs remain important in this application.

MARKET DYNAMICS

Driving Factor

Rising colorectal and bladder disease burden.

Growing incidence of colorectal cancer, inflammatory bowel disease, diverticulitis and bladder cancer increases the number of patients who require a colostomy, ileostomy or urostomy. In the United States alone, about 100,000 ostomy surgeries are performed each year, and every new patient becomes a long term user of pouches, barriers and accessories. Ageing populations raise surgical volumes because bowel and urological conditions become more common with age. Improved cancer screening and trauma care also keep more people alive after surgery, which extends the time they use ostomy products. Because supplies are replaced every few days, this expanding patient base creates dependable and repeat demand for manufacturers, distributors and home delivery suppliers in the stoma & ostomy care market.

Driver Impact Analysis*

Restraining Factor

High product cost and reimbursement gaps.

Ostomy supplies are used continuously, so the cost to patients and health systems accumulates quickly. Premium convex systems, ceramide barriers and accessories are priced higher than standard options, and coverage rules differ by country and payer. In many developing economies, patients rely on out of pocket spending and may stretch pouch wear time beyond recommended limits, which increases skin damage and leakage. Reimbursement ceilings in public programs can also pressure manufacturer margins and limit access to newer designs. Limited availability of trained stoma nurses further restricts correct product fitting, so patients may continue using unsuitable products. These affordability and access gaps slow the adoption of advanced products across price sensitive regions.

Restraint Impact Analysis*

Digital monitoring and personalized fitting.

Opportunity

Digital health creates strong openings for the stoma & ostomy care market. Sensor based leakage alerts, mobile applications and remote nurse consultations help patients manage output, skin condition and supply orders with greater confidence. Personalized fitting tools that use stoma shape scanning or guided measurement can reduce trial and error and lower product waste. Emerging economies in Asia Pacific, Latin America and the Middle East & Africa also offer scope because surgical capacity and awareness programs are improving. Companies that combine product innovation with education, home delivery and data driven patient support can build loyalty, expand into underserved populations and differentiate their brands beyond price.

Skin complications and patient stigma.

Challenge

Peristomal skin complications remain a persistent challenge because adhesive barriers must hold securely while protecting sensitive skin. Moisture, leakage, hernia and body shape changes can cause irritation, which leads to product switching and extra clinical visits. Social stigma and limited public awareness also reduce patient confidence, delay discussion of problems and discourage open conversations about stoma care. Manufacturers must invest in clinical evidence, nurse training and patient communities to address these barriers. Supply chain pressure on adhesives, polymer films and medical grade materials adds another layer of complexity, since consistent quality is essential for products that people depend on every day.

• Download Free Sample to learn more about this report

•  

STOMA & OSTOMY CARE MARKET REGIONAL INSIGHTS

• North America

North America holds 36% share of the stoma & ostomy care market and remains the leading region. An estimated 725,000 Americans live with an ostomy, and about 100,000 ostomy surgeries are performed each year in the United States, which gives manufacturers a large and continuous user base. Hollister Incorporated, widely regarded as the largest ostomy care company in North America, and Coloplast maintain strong relationships with hospitals, wound ostomy continence nurses and home delivery suppliers. Insurance coverage, Medicare benefits and established durable medical equipment channels help patients receive supplies on a regular schedule. Canada contributes through provincial assistance programs and a growing home care network.

• Europe

Europe accounts for 31% share of the stoma & ostomy care market and benefits from strong public healthcare systems. Coloplast, founded in Denmark in 1954, and Convatec, a United Kingdom based company, are among the leading global companies with deep European roots. About 200,000 people in the United Kingdom live with a stoma, and ostomy products are available on prescription through the National Health Service. Germany, France, Italy and Spain also provide structured reimbursement and nurse supported care, which encourages the use of modern pouching systems. Convatec has reported ostomy care growth led by Europe in 2026, supported by the Esteem Body launch. Nordic countries lead in patient education and product innovation, while Southern and Eastern Europe show rising adoption of premium accessories. Tender based purchasing in public hospitals creates price pressure, yet it also rewards suppliers with consistent quality and clinical support. Europe therefore remains a stable and innovation focused region.

• Asia Pacific

Asia Pacific holds 21% share of the stoma & ostomy care market and ranks behind North America and Europe. China, Japan, India, South Korea and Australia drive most demand because of large populations, rising colorectal cancer detection and expanding surgical capacity. Japan and Australia have mature ostomy care systems with strong nurse training and government support, while China and India are building awareness and distribution networks. Regional manufacturers such as Bao-Health compete on affordability and local relationships, while international leaders such as Convatec, which serves about 90 countries, expand through distributors and nurse education programs. Ageing populations in Japan and South Korea increase long term demand for pouches and skin care accessories. Rising incomes, better hospital infrastructure and growing medical tourism support adoption of premium products. Limited reimbursement in several countries still keeps cost sensitive buyers focused on basic pouching systems, yet the growth outlook remains strong.

• Middle East & Africa

Middle East & Africa accounts for 7% share of the stoma & ostomy care market, ahead of Rest of the World at 5%. Demand is concentrated in Gulf Cooperation Council countries, Turkey, Israel, Egypt and South Africa, where private hospitals, government funded procedures and medical tourism support ostomy surgeries. Saudi Arabia and the United Arab Emirates are investing in specialist hospitals, oncology services and nurse training, which improves access to modern ostomy products. In many African countries, supply remains limited, and charities, donations and low cost imports play a significant role. Distributors are central because few manufacturers operate locally, and import approvals, currency swings and pricing differences can delay product availability. Awareness campaigns and professional education can help reduce stigma and improve product use. Partnerships with hospitals and nurse training programs help suppliers build trust. 

• Rest of the World

Rest of the World holds 5% share of the stoma & ostomy care market and mainly includes Latin America, along with other smaller markets. Brazil, Mexico, Argentina, Chile and Colombia are the main demand centers, supported by public hospital programs, private insurance and growing patient associations. Convatec has reported ostomy care growth led by Europe and Latin America in 2026, which shows rising interest in this region. Coloplast, Hollister Incorporated and B. Braun serve the region through distributors, hospital contracts and nurse education. Public procurement is common, so price competitiveness and supply reliability matter. Currency volatility and uneven reimbursement can limit adoption of premium products, but better surgical access and awareness programs are widening the patient base. Local manufacturing partnerships and digital ordering platforms can help suppliers improve service quality and reduce delivery times across the region.

KEY INDUSTRY PLAYERS

The stoma & ostomy care market is led by global vendors with broad portfolios, clinical credibility and strong nurse networks. Coloplast, Hollister Incorporated and Convatec shape the competitive landscape through skin barrier technology, digital tools and patient support programs. B. Braun, Alcare, Nu-Hope, Marlen, Welland Medical, Bao-Health, Flexicare Medical, Cymed, Schena, Perma-Type, 3M and Smith & Nephew add specialized strengths in accessories, regional distribution and wound care adjacency. Competitive strategies include soft convex launches, ceramide skin protection, home delivery services, nurse education, distributor partnerships and sustainability programs. Emerging players focus on affordability, customization and local access, which increases competition in price sensitive regions.

LIST OF TOP STOMA & OSTOMY CARE COMPANIES

• Convatec
• Coloplast
• Hollister Incorporated
• B. Braun
• Alcare
• Nu-Hope
• Marlen
• Welland Medical
• Bao-Health
• Flexicare Medical
• Cymed
• Schena
• Perma-Type
• 3M
• Smith & Nephew

LEADER INSIGHTS

• Convatec: Jonny Mason, Chief Executive Officer, highlighted substantial long-term growth opportunities in chronic care through the company's Accelerate strategy. He emphasized innovation, expanding patient access, and strengthening commercial capabilities, with Ostomy Care expected to achieve mid-to-high single-digit organic growth over the medium term. (Published: April 9, 2026 | Source: https://www.convatecgroup.com)

• Coloplast: Gavin Wood, President and Chief Executive Officer, leads the company's next phase of growth as its chronic care strategy targets greater market penetration, particularly in the United States and emerging markets. Coloplast's strategic outlook emphasizes expanding access to advanced ostomy care solutions, strengthening its SenSura Mio portfolio, and investing in innovation to support long-term patient demand. This reflects the company's published strategy rather than a directly verified statement from Wood. (Published: September 2, 2025 | Source: https://www.coloplast.com)

INVESTMENT ANALYSIS AND OPPORTUNITIES

Investment in the stoma & ostomy care market is moving toward innovation, manufacturing capacity and digital patient support. Convatec launched its Accelerate strategy in April 2026, and it serves about 90 countries, which shows the scale needed to compete globally. Coloplast has also revised its long term financial ambition while continuing to invest in chronic care. Opportunities include soft convex systems, skin health technologies, sensor based monitoring and subscription delivery. Emerging regions offer additional potential through nurse training, distributor partnerships and local access programs. Investors also look at sustainability, automation and clinical evidence as drivers that can improve margins and strengthen brand loyalty.

NEW PRODUCT DEVELOPMENT

New product development in the stoma & ostomy care market centers on leak protection, skin health and discretion. Coloplast introduced Heylo in 2024 as a digital leakage notification solution, giving users earlier warning and greater control. Convatec developed Esteem Body as a soft convex 1-piece system with leak defense and water repellent fabric, and plans Natura Body, a 2-piece soft convex system, for 2027. Hollister Incorporated continues to build on CeraPlus ceramide barriers, which are designed to support peristomal skin. Manufacturers are also working on thinner films, odor control, moldable barriers and recyclable packaging. These innovations aim to reduce complications, extend wear time and improve everyday confidence for patients.

RECENT DEVELOPMENTS

• April 2026: Convatec unveils Accelerate strategy to drive growth across ostomy care and chronic care categories. Convatec presented its Accelerate strategy at a London Capital Markets Day to scale innovation, manufacturing and customer-focused growth across ostomy, wound, continence and infusion care.

• November 2026: Coloplast reports 6% organic ostomy care growth and revises financial ambition toward 2030. Coloplast published full-year 2025/26 results and revised ambitions, showing global ostomy care momentum and chronic care investment, supported by pouching innovation and digital leakage technology.

REPORT COVERAGE

This report on the stoma & ostomy care market covers segmentation by type, application and region, with analysis of market dynamics, latest trends, investment opportunities and product development. Type coverage includes ostomy care bags and ostomy care accessories, while application coverage spans home care and hospitals & ambulatory surgical centers. Regional analysis includes 5 regions, namely North America, Europe, Asia Pacific, Middle East & Africa and Rest of the World. The competitive section profiles 15 companies, including Convatec, Coloplast, Hollister Incorporated and B. Braun, and reviews strategies, partnerships and recent developments. The scope helps manufacturers, suppliers and investors understand demand patterns and competitive positioning.